58F-91542-04673
3 vaccinations
1 coded response
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 752 / TX
- Registered
- 2022-01-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-01
Dose 1 — Pfizer-BioNTech
-
2021-03-01
Dose 2 — Pfizer-BioNTech
-
2022-01-04
Dose 3 — Pfizer-BioNTech
-
2022-01-05
Registered in v-safe
- 2022-01-05
- 2022-01-06
- 2022-01-07
- 2022-01-08
- 2022-01-09
- 2022-01-10
-
2022-01-11
Health check-in — day 7, dose 3Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-01-18
- 2022-01-25
- 2022-02-01
- 2022-02-08
-
2022-02-15
Survey response — day 42, dose 3MedDRA: Fatigue, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Congestion, runny nose, fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-04-05
- 2022-07-05
- 2023-01-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-01 | Pfizer-BioNTech | No |
| 2 | 2021-03-01 | Pfizer-BioNTech | No |
| 3 | 2022-01-04 | Pfizer-BioNTech | No |
Free text
Release 11 — day 42, dose 3
Symptoms: Congestion, runny nose, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release